Purity.
Potency.
Performance.

Origin

A 39-amino-acid synthetic peptide studied for dual incretin agonism.

Research Mechanism

Research literature describes co-activation of GIP and GLP-1 receptors in metabolic-signaling models.

Observed Research Half-Life

Approximately 5 days in documented research contexts.

Research Study Window

Weekly observation intervals in published study designs.

An investigational profile focused on dual-receptor metabolic signaling.

Origin

An investigational triple agonist studied in controlled metabolic research models.

Research Mechanism

Research literature describes simultaneous GLP-1, GIP, and glucagon receptor activation.

Observed Research Half-Life

Approximately 6 days in documented research contexts.

Research Study Window

Weekly observation intervals in published study designs.

An investigational profile focused on multi-receptor pathway signaling.

Origin

A four-amino-acid pineal-derived peptide studied in controlled research models.

Research Mechanism

Research literature describes telomerase and circadian-pathway observations in preclinical contexts.

Observed Research Half-Life

Short systemic presence with longer downstream observations in documented models.

Research Study Window

20 days in published study designs.

An investigational profile centered on chronobiological and telomerase-related documentation.

Origin

A gastric-derived peptide sequence studied in controlled research models.

Research Mechanism

Research literature describes VEGF and nitric-oxide pathway signaling in preclinical contexts.

Observed Research Half-Life

Approximately 4–6 hours in documented research contexts.

Research Study Window

4–6 weeks in published study designs.

An investigational profile centered on angiogenic signaling and tissue-model documentation.

Origin

A 43-amino-acid fragment of Thymosin β-4 studied in controlled research models.

Research Mechanism

Research literature describes G-actin sequestration in cell-migration and vascular-model studies.

Observed Research Half-Life

Approximately 2–3 days in documented research contexts.

Research Study Window

6–8 weeks in published study designs.

An investigational profile focused on actin dynamics and connective-tissue modeling.

Origin

Nicotinamide adenine dinucleotide documented in controlled biochemical research models.

Research Mechanism

Research literature describes its role as a substrate in sirtuin and cellular-energy pathways.

Observed Research Half-Life

Variable by model, with tissue residence observed in documentation-based contexts.

Research Study Window

Serial observation windows in published study designs.

An investigational profile centered on coenzyme-mediated cellular signaling.

Origin

A selective pentapeptide analog studied in controlled ghrelin-receptor models.

Research Mechanism

Research literature describes selective GHRP signaling in documentation-based contexts.

Observed Research Half-Life

Approximately 2 hours in documented research contexts.

Research Study Window

8–12 weeks in published study designs.

An investigational profile centered on selective secretagogue signaling.

Origin

A 16-amino-acid, mitochondrial-DNA-encoded peptide studied in controlled research models.

Research Mechanism

Research literature describes AMPK-pathway activity in mitochondrial metabolic models.

Observed Research Half-Life

Approximately 3–4 hours in documented research contexts.

Research Study Window

4 weeks in published study designs.

An investigational profile centered on mitochondrial metabolic signaling.

Origin

Growth Factor LR3 (GF-LR3) is a modified 83-amino-acid growth-factor analog studied in controlled research models.

Research Mechanism

Research literature describes IGF-pathway signaling, cellular proliferation, and satellite-cell models.

Observed Research Half-Life

Approximately 20–30 hours in documented research contexts.

Research Study Window

4–6 weeks in published study designs.

An investigational profile focused on IGF signaling and cellular-model documentation.

Origin

A modified 30-amino-acid GHRH analog studied in controlled research models.

Research Mechanism

Research literature describes sustained GHRH-pathway signaling and pulsatile secretion models.

Observed Research Half-Life

Approximately 6–8 days with DAC in documented research contexts.

Research Study Window

8–12 weeks in published study designs.

An investigational profile centered on extended GHRH-pathway observation.

Origin

An endogenous tripeptide–copper complex studied in controlled research models.

Research Mechanism

Research literature describes fibroblast signaling and MMP modulation in extracellular-matrix models.

Observed Research Half-Life

Approximately 30 minutes systemically, with longer residence observed in tissue models.

Research Study Window

8–12 weeks in documentation-based study designs.

An investigational profile centered on copper-peptide and extracellular-matrix signaling.